| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1404817B1 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 03/22/2006 | EP1338281B1 Method for producing an immunotropic antiviral preparation |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP1322162B1 Disinfectant agent |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1149171B1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 03/22/2006 | EP1090123B1 Polyketides and their synthesis |
| 03/22/2006 | EP1020426B9 Amine derivatives and process for producing the same |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0789564B1 Polynucleotide compositions |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751028A Non-nucleoside reverse transcriptase inhibitors |
| 03/22/2006 | CN1750819A A method of treatment or prophylaxis of symptoms of herpes viral infection |
| 03/22/2006 | CN1749277A Heat shock protein 65-human SARS coronary virus epitope antigen recombinant fusion protein (HSP65SARS/3CL161-264) |
| 03/22/2006 | CN1749256A Novel oxazolidone derivative, its preparing method and use |
| 03/22/2006 | CN1748797A Polyepitope DNA vaccine of anti-simple herpes virus-2 infection and its preparing method |
| 03/22/2006 | CN1748796A Tuberculosis transgenic vaccine and its preparing method |
| 03/22/2006 | CN1748795A Polyvalent avian flu recombinant live carrier vaccine |
| 03/22/2006 | CN1748791A Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method |
| 03/22/2006 | CN1748788A Recombinant human interferon alpha 26 injection of prefilled injector package |
| 03/22/2006 | CN1748782A Chinese medicine composition for treating and preventing bee bacteriosis and its preparing method |
| 03/22/2006 | CN1748781A Hepatitis recovery preparation and new preparing method |
| 03/22/2006 | CN1748776A Anti-virus lozenge or anti-virus chewing tablet and its preparing method |
| 03/22/2006 | CN1748756A Adhesive plaster for treating parotitis and its preparing method |
| 03/22/2006 | CN1748744A Chinese medicine for treating beri-beri and its producing method |
| 03/22/2006 | CN1748738A Chinese medicine cinnamon twig and poria dripping pill and its preparing method |
| 03/22/2006 | CN1748737A Xiaojin preparation and new preparing method |
| 03/22/2006 | CN1748736A New medicine administration path for reducing heat and detoxicating injection an dits preparing process |
| 03/22/2006 | CN1748721A Chinese medicine extracted liquid for preventing and treating bee fungus disease and its preparing method |
| 03/22/2006 | CN1748717A Method for prparing bee glue-ethyl cellulose microcapsule |
| 03/22/2006 | CN1748712A Process for producing neogenetic bovine serum of bovine virus diarrhea virus anti-body negativity for producing swine fever vaccine |
| 03/22/2006 | CN1748711A Anti-rabies immune blood plasma and its preparing method |
| 03/22/2006 | CN1748710A Anti-tetanus immunological blood plasma and its preparing method |
| 03/22/2006 | CN1748708A Clindamycin hydrochloride vaginal effervescent tablet and its preparing method |
| 03/22/2006 | CN1748672A Aseptic medicine composition |
| 03/22/2006 | CN1246331C Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment |
| 03/22/2006 | CN1246327C Novel 8A-and 9A-15-membered lactams |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246039C Moxilfloxacin formulation containing common salt |
| 03/22/2006 | CN1246038C Systemic delivery of oral vaccines of botulinus toxin |
| 03/22/2006 | CN1246032C Medicine for curing hepatitis B and preparing method thereof |
| 03/22/2006 | CN1246029C Medicine for treating herpes zoster |
| 03/22/2006 | CN1246007C Medicine for preventing cold |
| 03/22/2006 | CN1246006C Multifunction health therapeutic external use liquid |
| 03/22/2006 | CN1246003C Medicine for treating piglet yellow dysentery or white dysentery and its preparation method |
| 03/22/2006 | CN1245996C Stick of sucking incense for reducing fever and antivirus |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245988C Use of ATAZANAVIR in HIV therapy |
| 03/22/2006 | CN1245955C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/22/2006 | CN1245954C Povidone iodine toothpaste and preparing method |
| 03/22/2006 | CN1245875C Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 03/21/2006 | US7015347 Stable no-delivering compounds |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015307 Process for purifying glycopeptide phosphonate derivatives |
| 03/21/2006 | US7015305 Process for preparing glycopeptide derivatives |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015228 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances |
| 03/21/2006 | US7015221 2,4-disubstituted triazine derivatives |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine |
| 03/21/2006 | US7015212 Thiazepine inhibitors of HIV-1 integrase |
| 03/21/2006 | US7015203 Macrolides |
| 03/21/2006 | US7015202 Adjust migration of monocytes, lymphocytes or interleukins; controllinginfections |
| 03/21/2006 | US7015017 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7014866 High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same |
| 03/21/2006 | US7014857 Anti-sepsis conjugate vaccine |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | US7014652 Methods for treating prostatitis |
| 03/21/2006 | CA2443214C Vaccine composition comprising human papilloma virus 16 l1 virus-like particle (hpv 16 l1 vlp), human papilloma virus 18 l1 virus-like particle (hpv 18 l1 vlp) and 3-de-o-acylatedmonphosphoryl lipid a (3d-mpl) and alum |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2282254C Hydroxyazepanes as inhibitors of glycosidase and hiv protease |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2189863C Mucoadhesive emulsions containing cyclodextrin |
| 03/21/2006 | CA2182272C Modified papilloma virus l2 protein and vlps formed therefrom |
| 03/16/2006 | WO2006028024A1 9-(1’,5’-dimethyl-1’-vinyl-4’-hexenyl)-4-hydroxy-7h-furo[3,2-g][1]benzopyran-7-one as antibacterial agent |
| 03/16/2006 | WO2006027694A1 Inhibitors of the hiv integrase enzyme |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2006027397A1 Spiropiperidyl rifamycins for the treatment of microbacterial infections |
| 03/16/2006 | WO2005105845A3 Phep, an amino acid permease of staphylococcus aureus |
| 03/16/2006 | WO2005087926A3 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 03/16/2006 | WO2005012337A3 Antigenic peptides of sars coronavirus and uses thereof |
| 03/16/2006 | US20060059579 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 03/16/2006 | US20060058570 Radioactive member and method of making |
| 03/16/2006 | US20060058503 Process for preparing glycopeptide derivatives |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058368 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058319 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 03/16/2006 | US20060058317 Oxazolidinone derivatives as antibacterial |